Hepatitis C (HCV) is a global disease. HCV in combination with Hepatitis B (HBV), now accounts for 75% of all cases of liver disease around the world. WCCT Global has become a leader in helping the research community better understand this disease through WCCT Global’s Hepatitis Center of Excellence.
Understanding the disease is key:
There [...]
Cypress, California and San Francisco – February 20th, 2012 – WCCT Global, LLC, a contract research organization (CRO) supporting early phase biopharmaceutical and device development, today announced its appointment of Mr. Lee A. Barsky, MBA, PMP to expand WCCT’s CRO offering.
WCCT Global specializes in complex Phase I-IIa special population studies, which assess a drug’s efficacy [...]
Company completes name change to WCCT Global, appoints Board of Directors and names founder and CEO Chairman of the Board
Cypress, California and San Francisco – January 10, 2012 – West Coast Clinical Trials, LLC (WCCT), a contract research organization (CRO) supporting early phase biopharmaceutical and device development, today announced it has received a [...]
On September 7, 2011,in Eur J Clin Pharmacol DOI 10.1007/s00228-011-1127-z
Cypress, CA, September 29, 2011
West Coast Clinical Trials, LLC (WCCT) is pleased to announce the publication of the ethnobridging Pharmacokinetic-Pharmacodynamic study of the novel, orally bioavailable, anti-platelet drug, vorapaxar, carried out in collaboration with Merck, Sharp and Dohme Corp (Eur J Clin Pharmacol DOI 10.1007/s00228-011-1127). Vorapaxar [...]
On November 5, 2011,in Annals of Allergy, Asthma & Immunology, Nov. 2011, 107:5suppl.1,P364
Cypress, CA, November 5, 2011
West Coast Clinical Trials, LLC (WCCT) is pleased to announce the presentation of results of a Hypothalamic-Pituitary- Adrenal Axis function study in children ages 2 – 11 years of age with Allergic Rhinitis. One hundred thirty-two (132) children completed [...]
Cypress, CA, September 29, 2011
Dr. Kenneth Kim gave a presentation entitled “Global Development Strategies – Emerging Trends” at the BioKorea 2011 Conference and Exhibition in Coex, Seoul, Korea on September 28, 2011. The conference was supported by the Korean Government in an effort to help the Korean Biotech Industry grow to world-wide prominence. Dr. Kim’s [...]
Cypress, CA – West Coast Clinical Trials, LLC just completed a clinical trial that tested the effect of a 6 week treatment with triamcinolone acetonide aqueous nasal spray vs. placebo on basal hypothalamic-pituitary-adrenal (HPA) axis function in children 2-11 years of age with Allergic Rhinitis.
This was a phase IV study to characterize the effect of [...]
Cypress, CA – West Coast Clinical Trials, LLC (WCCT.com) announced today the appointment of Melton Affrime, PharmD as Senior Vice President, Research and Development, to further develop their growing clinical research capabilities.
Mel Affrime comes with a wealth of experience within the industry, having spent the last five years at ICON Development Solutions as Chief Scientific [...]
WCCT successfully completes a thorough QT cardiac safety study on schedule with a confinement period of 30 days with a complex exercise component.
Cypress, California (PRWEB) June 09, 2011
West Coast Clinical Trials (WCCT) has completed its most recent thorough tQT trial. This thorough tQT study, required a unique Modified Bruce Protocol component while collecting cardiac rhythm [...]
WCCT recently completed its largest cerebrospinal cerebral spinal fluid (CSF) Pharmacokinetic (PK) sampling study. The typical CSF collection study has 6-8 subjects receiving single or serial samples. The recent study completed by WCCT enrolled and completed an astonishing total of 48 healthy subjects who were confined in-house for a period of 16 days while undergoing [...]